These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 37134043)
1. Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinoma. Chai F; Zhang J; Fu T; Jiang P; Huang Y; Wang L; Yan S; Yan X; Yu L; Xu Z; Wang R; Xu B; Du X; Jiang Y; Zhang J Channels (Austin); 2023 Dec; 17(1):2208928. PubMed ID: 37134043 [TBL] [Abstract][Full Text] [Related]
2. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis. Huang J; Liang B; Wang T Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372 [TBL] [Abstract][Full Text] [Related]
3. FSCN1 is upregulated by SNAI2 and promotes epithelial to mesenchymal transition in head and neck squamous cell carcinoma. Wang L; Jia Y; Jiang Z; Gao W; Wang B Cell Biol Int; 2017 Aug; 41(8):833-841. PubMed ID: 28488774 [TBL] [Abstract][Full Text] [Related]
4. Stabilization of Slug by NF-κB is Essential for TNF-α -Induced Migration and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma Cells. Liu S; Shi L; Wang Y; Ye D; Ju H; Ma H; Yang W; Wang Y; Hu J; Deng J; Zhang Z Cell Physiol Biochem; 2018; 47(2):567-578. PubMed ID: 29794474 [TBL] [Abstract][Full Text] [Related]
5. p53 modulates NF-κB mediated epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma. Lin Y; Mallen-St Clair J; Luo J; Sharma S; Dubinett S; St John M Oral Oncol; 2015 Oct; 51(10):921-8. PubMed ID: 26306422 [TBL] [Abstract][Full Text] [Related]
6. miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma. Mei LL; Wang WJ; Qiu YT; Xie XF; Bai J; Shi ZZ Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28832500 [TBL] [Abstract][Full Text] [Related]
7. NT5E upregulation in head and neck squamous cell carcinoma: A novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment. Chen XM; Liu YY; Tao BY; Xue XM; Zhang XX; Wang LL; Zhong H; Zhang J; Yang SM; Jiang QQ Front Immunol; 2022; 13():975847. PubMed ID: 36091055 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of the Role of Chu M; Zheng K; Li X; Luo Z; Yang X; Wei C Anal Cell Pathol (Amst); 2022; 2022():2371057. PubMed ID: 36247875 [TBL] [Abstract][Full Text] [Related]
9. A Prognosis Marker SLC2A3 Correlates With EMT and Immune Signature in Colorectal Cancer. Gao H; Liang J; Duan J; Chen L; Li H; Zhen T; Zhang F; Dong Y; Shi H; Han A Front Oncol; 2021; 11():638099. PubMed ID: 34211835 [TBL] [Abstract][Full Text] [Related]
10. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. Sun K; Chen RX; Li JZ; Luo ZX Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of HOX genes promotes cell migration and proliferation in head and neck squamous cell carcinoma. Aguiar GM; Ramão A; Plaça JR; Simões SC; Scaraboto NV; Freitas-Castro F; Cardoso C; Sousa JF; Silva WA Tumour Biol; 2021; 43(1):263-278. PubMed ID: 34633333 [TBL] [Abstract][Full Text] [Related]
12. Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients-An Integrated Bioinformatics Approach. Gong X; Ren F Dis Markers; 2022; 2022():5239033. PubMed ID: 35711568 [TBL] [Abstract][Full Text] [Related]
13. Clinical powers of Aminoacyl tRNA Synthetase Complex Interacting Multifunctional Protein 1 (AIMP1) for head-neck squamous cell carcinoma. Li Y; Liu H Cancer Biomark; 2022; 34(3):359-374. PubMed ID: 35068446 [TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic analysis of BGN in head and neck squamous cell carcinoma. Zhao L; Liang J; Zhong W; Han C; Liu D; Chen X Gene; 2022 Jun; 827():146461. PubMed ID: 35358652 [TBL] [Abstract][Full Text] [Related]
15. Claudin-1 mediates progression by regulating EMT through AMPK/TGF-β signaling in head and neck squamous cell carcinoma. Chang JW; Seo ST; Im MA; Won HR; Liu L; Oh C; Jin YL; Piao Y; Kim HJ; Kim JT; Jung SN; Koo BS Transl Res; 2022 Sep; 247():58-78. PubMed ID: 35462077 [TBL] [Abstract][Full Text] [Related]
16. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study. Li C; Chen S; Liu C; Mo C; Gong W; Hu J; He M; Xie L; Hou X; Tang J; Ou M Hereditas; 2022 Sep; 159(1):37. PubMed ID: 36167571 [TBL] [Abstract][Full Text] [Related]
17. Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma. Chen Y Dis Markers; 2022; 2022():6410113. PubMed ID: 35756491 [TBL] [Abstract][Full Text] [Related]
18. Identification of genetic mechanisms underlying lipid metabolism-mediated tumor immunity in head and neck squamous cell carcinoma. Liu S; Wang S; Wang Z BMC Med Genomics; 2023 May; 16(1):110. PubMed ID: 37210507 [TBL] [Abstract][Full Text] [Related]
19. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2). Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759 [TBL] [Abstract][Full Text] [Related]
20. FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma. Wu Q; Shao T; Huang G; Zheng Z; Jiang Y; Zeng W; Lv X Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291667 [No Abstract] [Full Text] [Related] [Next] [New Search]